Form EFFECT Coya Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 20, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
- Jotform Introduces AI App Builder, Turning Ideas Into Fully Functional Apps in Minutes
- AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
